These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11056429)

  • 1. Stevens-Johnson syndrome-like exanthema secondary to methotrexate histologically simulating acute graft-versus-host disease.
    Hani N; Casper C; Groth W; Krieg T; Hunzelmann N
    Eur J Dermatol; 2000; 10(7):548-50. PubMed ID: 11056429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
    Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
    Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimorphic exanthema manifested as reticular maculopapular exanthema and erythema multiforme major associated with pyrazolon derivatives.
    Chen W; Hsieh FS
    Eur J Dermatol; 2002; 12(5):488-90. PubMed ID: 12370143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal skin toxicity related to methotrexate sparing psoriatic plaques.
    Truchuelo T; Alcántara J; Moreno C; Vano-Galván S; Jaén P
    Dermatol Online J; 2010 Jun; 16(6):16. PubMed ID: 20579471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
    Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
    J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors.
    Severino G; Chillotti C; De Lisa R; Del Zompo M; Ardau R
    Ann Pharmacother; 2005 Jan; 39(1):162-4. PubMed ID: 15546944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson syndrome induced by carbamazepine.
    Czajkowski R; Weiss-Rostkowska V; Wankiewicz A; Drewa T; Placek W; Biedka M; Zegarska B
    Acta Pol Pharm; 2007; 64(1):89-92. PubMed ID: 17665856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apparent worsening of psoriasis lesions revealing methotrexate overdosage].
    Haber R; Baroudjian B; Battistella M; Bagot M; Petit A
    Ann Dermatol Venereol; 2018 Feb; 145(2):104-108. PubMed ID: 28917574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of acute cutaneous graft-versus-host disease mimicking psoriasis vulgaris.
    Matsushita T; Hasegawa M; Shirasaki F; Fujimoto M; Yamazaki H; Sato S; Takehara K
    Dermatology; 2008; 216(1):64-7. PubMed ID: 18032902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute severe methotrexate toxicity in patients with psoriasis: a case series and discussion.
    Yélamos O; Català A; Vilarrasa E; Roé E; Puig L
    Dermatology; 2014; 229(4):306-9. PubMed ID: 25401478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
    Salim A; Tan E; Ilchyshyn A; Berth-Jones J
    Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus, pregnancy, and Stevens-Johnson syndrome.
    Shilad A; Predanic M; Perni SC; Houlihan C; Principe D
    Obstet Gynecol; 2005 May; 105(5 Pt 2):1254-6. PubMed ID: 15863600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of bupropion-induced Stevens-Johnson syndrome with acute psoriatic exacerbation.
    Surovik J; Riddel C; Chon SY
    J Drugs Dermatol; 2010 Aug; 9(8):1010-2. PubMed ID: 20684153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate-induced toxic epidermal necrolysis in a patient with psoriasis.
    Primka EJ; Camisa C
    J Am Acad Dermatol; 1997 May; 36(5 Pt 2):815-8. PubMed ID: 9146556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blistering drug reactions].
    Roujeau JC
    Rev Prat; 2000 Jun; 50(12):1320-3. PubMed ID: 10972073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute renal failure and its risk factors in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Hung CC; Liu WC; Kuo MC; Lee CH; Hwang SJ; Chen HC
    Am J Nephrol; 2009; 29(6):633-8. PubMed ID: 19155617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 and its soluble receptor in selected drug-induced cutaneous reactions.
    Chodorowska G; Czelej D; Niewiedzioł M
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):7-13. PubMed ID: 15323158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous ulceration caused by methotrexate.
    Kazlow DW; Federgrun D; Kurtin S; Lebwohl MG
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl Case Reports):S197-8. PubMed ID: 12894123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.